about
Parvovirus infection mimicking systemic lupus erythematosus.Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complexNew LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infectionsPure red cell aplasia.The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells.Human parvovirus B19 infection in pregnancy: should screening be offered to the low-risk population?Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway.Human Parvoviruses.Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient.Lupus anticoagulant in a patient with parvovirus B19 infection.Acute anemic events in sickle cell disease.Evidence of parvovirus B19 infection in patients of pre-eclampsia and eclampsia with dyserythropoietic anaemia.Severe acral pruritus associated with parvovirus B19 infection.Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies.Human Parvovirus B19 Utilizes Cellular DNA Replication Machinery for Viral DNA Replication.
P2860
Q30550505-5D960CD1-C93D-4E39-954B-6DCB97E83CC5Q33664467-EE3477D4-828A-47E8-8C0B-812272B901EBQ33974299-BFC6C559-DF91-43FF-90A6-54288AD81830Q34135285-F6C75BCA-2EFF-4635-AAC3-BD420E497D5BQ34676329-8340D3B0-902D-4D3B-A474-C5BAF6C224A4Q34981813-03FAEC2A-8506-453D-9315-A479DB7053C0Q35139637-391C53F2-7E05-4C3D-8940-3EC126653CE5Q36298400-A8C5EC4F-9844-434F-BCEB-F571487D96B7Q38996997-83F00479-B2DC-4991-A831-7E8B59A5B13DQ40571294-86AA0D0A-77B1-428C-AB1F-199B5E6A3D73Q42052491-26AB3AE7-523F-4D30-A745-06896B2661A2Q43627419-3F198C63-622F-4E4E-A3BC-B50E9A2A680BQ44057248-6F9A76B3-D599-43AF-9E21-47713F8E7BFCQ44496993-DB411858-C060-4119-AC65-726F6347A815Q44981840-8FFE55DE-FCD8-4DD3-A342-D461421DAB5EQ45210363-5A74B126-6003-4C1E-9B35-6C2B5BB14C71Q45767936-1D42896A-64CC-4235-B2AA-D168A686DCBAQ47296251-1D2FFAF1-13DF-4312-B2B3-0A7BDDF418BA
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Parvovirus B19 in human disease.
@en
type
label
Parvovirus B19 in human disease.
@en
prefLabel
Parvovirus B19 in human disease.
@en
P1476
Parvovirus B19 in human disease.
@en
P2093
P356
10.1146/ANNUREV.MED.48.1.59
P577
1997-01-01T00:00:00Z